Pediatric Cancer Genome Project
St. Jude Cloud
Data Resource:  St. Jude Cloud
Point of Contact:  
Clay McLeod ; Jinghui Zhang,  
Project

About This Dataset
Core Data Elements
Number of Cases
1,630
Case Sex
Female (542); Male (660); Not Reported (428)
Case Age At Diagnosis
0 to 4 years (390); 5 to 9 years (253); 10 to 14 years (202); 15 to 19 years (158); 20 to 24 years (17); 25 to 29 years (1); 30 to 34 years (1); Pediatric and Young Adult (<40 years) (608)
Case Race
Asian (13); Black or African American (149); More Than One Race (2); Native Hawaiian or Other Pacific Islander (1); White (577); Not Reported (888)
Case Ethnicity
Hispanic or Latino (49); Not Hispanic or Latino (569); Not Reported (1,012)
Case Disease Diagnosis
Acute Megakaryoblastic leukemia (20); Adrenocortical Tumor (39); AE (1); B-cell Acute Lymphoblastic Leukemia, E2A-PBX1 (51); B-cell Acute Lymphoblastic Leukemia, ERG (37); B-cell Acute Lymphoblastic Leukemia, ETV6-RUNX1 (53); B-cell Acute Lymphoblastic Leukemia, NOS (78); Choroid Plexus Carcinoma (4); Core Binding Factor Acute Myeloid Leukemia (75); Core Binding Factor Acute Myeloid Leukemia;AE (1); Core Binding Factor Acute Myeloid Leukemia;inv(16) (10); Ependymoma, NOS (61); Ewing's Sarcoma (19); HGG (2); High grade glioma (94); High grade glioma;DIPG (3); High grade neuroepithelial tumor (1); Hyperdiploid Acute Lymphoblastic Leukemia (69); Hypodiploid Acute Lymphoblastic Leukemia (35); Infantile Acute Lymphoblastic Leukemia (31); inv(16) (1); Lineage:B,Primary_subtype:B-other (4); Lineage:B,Primary_subtype:DUX4 (30); Lineage:B,Primary_subtype:DUX4,Secondary_subtype:ETV6-RUNX1-like (2); Lineage:B,Primary_subtype:ETV6-RUNX1-like (1); Lineage:B,Primary_subtype:ETV6-RUNX1-like,Secondary_subtype:iAMP21 (1); Lineage:B,Primary_subtype:Hyperdiploid (5); Lineage:B,Primary_subtype:Hyperdiploid,Secondary_subtype:Ph-like_non CRLF2 (1); Lineage:B,Primary_subtype:iAMP21 (6); Lineage:B,Primary_subtype:KMT2A-like (1); Lineage:B,Primary_subtype:MEF2D (4); Lineage:B,Primary_subtype:Near haploid,Secondary_subtype:Ph-like_non CRLF2 (1); Lineage:B,Primary_subtype:PAX5 P80R (2); Lineage:B,Primary_subtype:PAX5alt (5); Lineage:B,Primary_subtype:PAX5alt,Secondary_subtype:Ph-like_non CRLF2 (1); Lineage:B,Primary_subtype:Ph (11); Lineage:B,Primary_subtype:Ph,Secondary_subtype:Hyperdiploid (3); Lineage:B,Primary_subtype:Ph-like_CRLF2,Secondary_subtype:iAMP21 (2); Lineage:B,Primary_subtype:Ph-like_non CRLF2 (20); Lineage:B,Primary_subtype:Ph-like_non CRLF2,Secondary_subtype:iAMP21 (3); Lineage:B,Primary_subtype:ZNF384 (1); Lineage:B,Primary_subtype:ZNF384-like (1); Lineage:T,Primary_subtype:T-other (1); Low grade glioma (38); Medulloblastoma (37); Melanoma, NOS (5); MLL Rearranged Leukemia (20); Neuroblastoma (100); Osteosarcoma, NOS (40); Ph+ Acute Lymphoblastic Leukemia (37); Retinoblastoma (1); Retinoblastoma, NOS (14); Rhabdomyosarcoma, NOS (41); T-cell Acute Lymphoblastic Leukemia (29); Not Reported (477)
Case Tumor Site
Not Reported (1,630)
Number of Samples
3,023
Sample Assay Method
RNA Sequencing (245); Whole Exome Sequencing (1,380); Whole Genome Sequencing (1,398)
Sample Is Xenograft
Yes (10)
Additional Data Elements
DATA REPOSITORY
Grant Information
P30CA021765
Cancer Center Support Grant
PROGRAM ID
PAR-17-095
Published In
https://doi.org/10.1038/ng.2287
SAMPLE TYPE
Autopsy (57);  
Cell Line (19);  
Diagnosis (1,514);  
Germline (1,293);  
Metastasis (28);  
Relapse (102);  
Charts
Male (660); Female (542); Not Reported (428)
660Male